CN Patent

CN104788300B — 欧司哌米芬多晶型

Assigned to Nanjing Huawe Medicine Technology Group Co Ltd · Expires 2017-01-11 · 9y expired

What this patent protects

本发明提供欧司哌米芬，化学名为(Z)‑2‑[4‑(4‑氯‑1，2‑二苯基‑丁‑1‑烯基)苯氧]乙醇的多晶型，其具有优异的稳定性，和可重现的晶体结构。另外，本发明亦提供欧司哌米芬多晶型的制备方法。

USPTO Abstract

本发明提供欧司哌米芬，化学名为(Z)‑2‑[4‑(4‑氯‑1，2‑二苯基‑丁‑1‑烯基)苯氧]乙醇的多晶型，其具有优异的稳定性，和可重现的晶体结构。另外，本发明亦提供欧司哌米芬多晶型的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104788300B
Jurisdiction
CN
Classification
—
Expires
2017-01-11
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Huawe Medicine Technology Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.